Most investigations of the effect of tempol have been carried out in animal models of disease, such as hypertension or substantial burdens of atherosclerotic plaques, including studies in old ApoE-/- mice showing that treatments with tempol and other SOD-mimicking agents increases the vasodilatory response to acetylcholine [12,43,44]. The gene discussed is APOE; the disease is hypertensive disorder.